LAZARD ASSET MANAGEMENT LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$84,000
+42.4%
20,567
+22.9%
0.00%
Q4 2021$59,000
+126.9%
16,736
+133.9%
0.00%
Q3 2021$26,000
-58.1%
7,156
-52.9%
0.00%
Q1 2021$62,000
+12.7%
15,178
+9.1%
0.00%
Q4 2020$55,0000.0%13,913
-32.3%
0.00%
Q3 2020$55,000
-8.3%
20,562
-6.4%
0.00%
Q2 2020$60,000
+46.3%
21,959
+23.7%
0.00%
Q1 2020$41,000
-6.8%
17,746
+86.6%
0.00%
Q4 2019$44,000
+238.5%
9,511
+127.9%
0.00%
Q3 2019$13,0004,1740.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders